Presentation is loading. Please wait.

Presentation is loading. Please wait.

Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: A randomized, placebo-controlled, multicenter clinical.

Similar presentations


Presentation on theme: "Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: A randomized, placebo-controlled, multicenter clinical."— Presentation transcript:

1 Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: A randomized, placebo-controlled, multicenter clinical trial  Keyvan Karkouti, MD, Christian von Heymann, MD, Christian M. Jespersen, MD, Wolfgang Korte, MD, Jerrold H. Levy, MD, Marco Ranucci, MD, Frank W. Sellke, MD, Howard K. Song, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 146, Issue 4, Pages (October 2013) DOI: /j.jtcvs Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Patient disposition. rFXIII, Recombinant factor XIII.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Factor XIII levels. Data shown are means and SDs. rFXIII, Recombinant factor XIII; TDA, trial drug administration. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions


Download ppt "Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: A randomized, placebo-controlled, multicenter clinical."

Similar presentations


Ads by Google